BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25191532)

  • 1. Vitamin D modulates biliary fibrosis in ABCB4-deficient mice.
    Hochrath K; Stokes CS; Geisel J; Pollheimer MJ; Fickert P; Dooley S; Lammert F
    Hepatol Int; 2014 Jul; 8(3):443-52. PubMed ID: 25191532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-(OH)₂-vitamin D₃ prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(-/-) model.
    Reiter FP; Hohenester S; Nagel JM; Wimmer R; Artmann R; Wottke L; Makeschin MC; Mayr D; Rust C; Trauner M; Denk GU
    Biochem Biophys Res Commun; 2015 Apr; 459(2):227-233. PubMed ID: 25712522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.
    Reiter FP; Wimmer R; Wottke L; Artmann R; Nagel JM; Carranza MO; Mayr D; Rust C; Fickert P; Trauner M; Gerbes AL; Hohenester S; Denk GU
    World J Hepatol; 2016 Mar; 8(8):401-10. PubMed ID: 27004088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
    Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
    PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
    Moustafa T; Fickert P; Magnes C; Guelly C; Thueringer A; Frank S; Kratky D; Sattler W; Reicher H; Sinner F; Gumhold J; Silbert D; Fauler G; Höfler G; Lass A; Zechner R; Trauner M
    Gastroenterology; 2012 Jan; 142(1):140-151.e12. PubMed ID: 22001865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of various ATP-binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC).
    Thoeni C; Perciani CT; Nakib D; Camat D; McGilvray ID; MacParland SA; Fischer S
    Histopathology; 2023 Oct; 83(4):559-568. PubMed ID: 37488782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice.
    Lamireau T; Bouchard G; Yousef IM; Clouzeau-Girard H; Rosenbaum J; Desmoulière A; Tuchweber B
    Pediatr Res; 2007 Feb; 61(2):185-90. PubMed ID: 17237720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
    Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
    J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blocking chemokine receptor CCR1 with BX471 in two models of fibrosis prevention and rescue in mice.
    Weber SN; Nowak I; Grünhage F; Lammert F
    Biochem Biophys Rep; 2021 Sep; 27():101077. PubMed ID: 34337167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
    Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
    Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice.
    Gonzalez-Sanchez E; El Mourabit H; Jager M; Clavel M; Moog S; Vaquero J; Ledent T; Cadoret A; Gautheron J; Fouassier L; Wendum D; Chignard N; Housset C
    Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166067. PubMed ID: 33418034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis.
    Hochrath K; Krawczyk M; Goebel R; Langhirt M; Rathkolb B; Micklich K; Rozman J; Horsch M; Beckers J; Klingenspor M; Fuchs H; Gailus-Durner V; Wolf E; Acalovschi M; Volmer DA; Hrabě de Angelis M; Lammert F
    FASEB J; 2012 Dec; 26(12):5081-91. PubMed ID: 22982378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles reflect sclerosing cholangitis activity in abcb4 (-/-) mice.
    Nakken KE; Nygard S; Haaland TK; Berge KE; Ødegaard A; Labori KJ; Raeder MG
    Scand J Gastroenterol; 2009; 44(2):211-8. PubMed ID: 18785065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.
    Mende S; Schulte S; Strack I; Hunt H; Odenthal M; Pryymachuck G; Quasdorff M; Demir M; Nierhoff D; Dienes HP; Goeser T; Steffen HM; Töx U
    Dig Dis Sci; 2013 May; 58(5):1271-81. PubMed ID: 23247798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling hepatic osteodystrophy in Abcb4 deficient mice.
    Hochrath K; Ehnert S; Ackert-Bicknell CL; Lau Y; Schmid A; Krawczyk M; Hengstler JG; Dunn J; Hiththetiya K; Rathkolb B; Micklich K; Hans W; Fuchs H; Gailus-Durner V; Wolf E; de Angelis MH; Dooley S; Paigen B; Wildemann B; Lammert F; Nüssler AK
    Bone; 2013 Aug; 55(2):501-11. PubMed ID: 23545228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice.
    Roderfeld M; Rath T; Voswinckel R; Dierkes C; Dietrich H; Zahner D; Graf J; Roeb E
    Hepatology; 2010 Jan; 51(1):267-76. PubMed ID: 19827165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variant c.711A>T in the hepatobiliary phospholipid transporter ABCB4 is associated with significant liver fibrosis.
    Smyk W; Weber SN; Hall R; Gruenhage F; Lammert F; Krawczyk M
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P; Fuchsbichler A; Wagner M; Zollner G; Kaser A; Tilg H; Krause R; Lammert F; Langner C; Zatloukal K; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2004 Jul; 127(1):261-74. PubMed ID: 15236191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.
    Rothweiler S; Feldbrügge L; Jiang ZG; Csizmadia E; Longhi MS; Vaid K; Enjyoji K; Popov YV; Robson SC
    Purinergic Signal; 2019 Sep; 15(3):375-385. PubMed ID: 31243614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/ - ) mice harbouring chronic cholangitis.
    Nakken KE; Nygård S; Haaland T; Berge KE; Arnkvaern K; Ødegaard A; Labori KJ; Raeder MG
    Scand J Gastroenterol; 2007 Oct; 42(10):1245-55. PubMed ID: 17852852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.